Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6faf2508cf82115c8f4e03820594bc5 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B65D83-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-02 |
filingDate |
2012-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5738346234a276b1662809d74826bc |
publicationDate |
2013-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2614833-A1 |
titleOfInvention |
Scarring reducing wound treatment |
abstract |
The present invention refers to the use of hemoglobin or myoglobin charged with a non-oxygen ligand for improved scarring of wounds. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3421044-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019002051-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458159-B2 |
priorityDate |
2012-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |